Edition:
United States

Tyme Technologies Inc (TYME.OQ)

TYME.OQ on NASDAQ Stock Exchange Capital Market

4.09USD
22 Jun 2018
Change (% chg)

$0.39 (+10.54%)
Prev Close
$3.70
Open
$3.72
Day's High
$4.35
Day's Low
$3.63
Volume
3,337,156
Avg. Vol
101,882
52-wk High
$9.50
52-wk Low
$2.01

Chart for

About

Tyme Technologies, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to... (more)

Overall

Beta: --
Market Cap(Mil.): $408.18
Shares Outstanding(Mil.): 99.80
Dividend: --
Yield (%): --

Financials

  TYME.OQ Industry Sector
P/E (TTM): -- 248.83 34.14
EPS (TTM): -0.21 -- --
ROI: -112.03 -5.25 13.10
ROE: -112.03 -6.83 15.09

BRIEF-Tyme Technologies prices offering of 9 mln shares at $2.25 a share

* TYME TECHNOLOGIES ANNOUNCES PRICING OF ITS OFFERING OF 9 MILLION SHARES OF COMMON STOCK

Mar 01 2018

BRIEF-Tyme Technologies Appoints Tommy Thompson To Board Of Directors

* TYME TECHNOLOGIES APPOINTS TOMMY G. THOMPSON TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Feb 21 2018

BRIEF-Tyme Technologies Says To Report Full Phase II Data For SM-88 In Second Half Of 2018

* TYME TECHNOLOGIES INC SAYS LOOK FORWARD TO REPORTING FULL PHASE II DATA FOR SM-88 IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:

Feb 08 2018

BRIEF-Tyme Provides Clinical And Corporate Update For Fiscal Q3 2017

* TYME PROVIDES CLINICAL AND CORPORATE UPDATE FOR FISCAL THIRD QUARTER 2017

Feb 07 2018

Earnings vs. Estimates